Lv21
200 积分 2022-08-03 加入
Rezvilutamide versus bicalutamide in combination with androgen-deprivation therapy in patients with high-volume, metastatic, hormone-sensitive prostate cancer (CHART): a randomised, open-label, phase 3 trial
4小时前
待确认
Fuzuloparib Maintenance Therapy in Patients With Platinum-Sensitive, Recurrent Ovarian Carcinoma (FZOCUS-2): A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase III Trial
5小时前
已完结
Effective Prevention and Management of Tumor Lysis Syndrome in Children With Cancer
12天前
已完结
Safety and efficacy of a dexamethasone-sparing regimen with daratumumab and lenalidomide in patients with frailty and newly diagnosed multiple myeloma (IFM2017-03): a phase 3, open-label, multicentre, randomised, controlled trial
13天前
已完结
Outcomes of frailty subgroups of older adults (age ≥ 70) treated with teclistamab: an International Myeloma Foundation immunotherapy database real-world analysis
13天前
已完结
Impact of pharmacist-led interventions on oncology drug therapy outcomes: a systematic review and meta-analysis
13天前
已完结
Evaluation and clinical impact of a pharmacist-led, interdisciplinary service focusing on education, monitoring and toxicity management of immune checkpoint inhibitors
14天前
已完结
Ixazomib, Daratumumab, and Low-Dose Dexamethasone in Frail Patients With Newly Diagnosed Multiple Myeloma: The Hovon 143 Study
19天前
已完结
How I Treat Tumor Lysis Syndrome
20天前
已关闭
Tumor Lysis Syndrome
20天前
已完结
皖公网安备34019202002308
